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Material and Methods: Data was obtained from the St. Luke's 
Radiation Oncology Network patient registry. Patients with 
stage III & IV non-metastatic laryngeal cancer who were fit 
for radical intervention and offered larynx preservation 
treatment were identified between 2008-2014. Those who 
were aged ≥ 65 years at the time of treatment were included 
in this study. 
 
Results: A total of 68 patients were identified who met the 
selection criteria. The majority of patients were male (88%) 
and between 65-74 years, with a median age of 70. Of the 
patients identified 6% of patients were changed from radical 
to palliative intent and received a radiation dose of ≤40Gy. 
Currently, 45% of patients are still alive with 10% having 
required salvage surgery in the form of total laryngectomy 
post treatment for local recurrence. Of those studied, 60% of 
patients received radiotherapy only and 40% received 
combined chemoradiation. Patients who had combined 
modality treatment had significant toxicity from 
chemotherapy related to myelosuppression and febrile 
neutropaenia. Among those who received chemotherapy 51% 
did not complete the prescribed chemotherapy course 
secondary to toxicity. There were 17 patients (25%) who 
required enteral feeding via a gastrostomy tube and 2 
requiring NG feeding during their treatment course. 
 
Conclusion: Patients who are 65 years or greater seem to 
tolerate combined chemoradiation poorly. The appropriate 
selection of patients suitable for larynx preservation 
treatment in this age group is vital in achieving comparable 
survival and outcomes to the published major trials.  
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Purpose or Objective: To evaluate the use of a new 
algorithm for making decisions in elderly early breast cancer 
patients after tumorectomy plus hormone therapy. 
 
Material and Methods: This is a prospective preliminary 
study stating in June 2014. According to the recommendation 
of the “Innovation and Best Practices” of the “IDC-Salud 
health group”, a new algorithm to manage elderly (> 70 
years) patients with early breast cancer after conservative 
surgery was designed. This procedure considered the results 
of the CALGB 9343 randomized trial for counseling patients 
about the convenience or not to use radiotherapy. Inclusion 
criteria included patients older than 70 years, early breast 
cancer (T ≤ 2cm, clinical N0), treated by tumorectomy. In 
order to decide whether or not to indicate external 
radiotherapy, the new algorithm took into account the 
following parameter: life expectation estimated by a 
specialist in Geriatric Oncology using primarily patients’ age 
and the Charlson Comorbidity Index Score. Decision was 
against to indicate radiotherapy in women fulfilling the 
following conditions: life expectation ≤ 5 years. Those 
patients were managed according to both the Canadian 
nomogram (www.tuftsmedicalcenter.org/ibtr/) which 
calculates the 10-years local recurrence risk; and the MD 
Anderson nomogram 
(www3.mdanderson.org/app/medcalc/bc_nomogram5/index.
cfm?pagename=opcs), which calculates the risk of 
mastectomy at both 5 and 10 years in elderly patients. The 
criteria to decide whether or not indicate radiation therapy 
in these patients was based on the calculated reduction in 
the rate of either local recurrence or mastectomy as follows: 
≤ 5% radiotherapy was not indicated; reduction between 5- 
10% individualize case, reduction ≥ 10% radiotherapy should 
be always indicated. All patients signed a consent form to 
participate in the study and to assume the risks of local 
recurrence and/or further mastectomy. 
 
Results: Since June 2014,191 women with breast cancer were 
attended. 14 for them, (7.3%) were older than 70 years. From 
them seven fulfill the inclusion criteria (3.6%) and were 
eligible for the study. They all accepted to be included in the 
study. Data related to decision making are shown in Table 1 
and 2. 
After a detailed discussion explaining in depth that the 
benefits of the treatment was below +/- 5% and the potential 
risks and side effects, 37.5% (3/7) declined to be treated 
being surprisingly those who potentially could be more 
benefited from this therapy as they were at higher risk of 
recurrence. 
 
Conclusion: Patients fulfilling the criteria represent a low 
proportion of breast cancer patients. This preliminary study 
suggests that cultural and psychological aspects should be 
taken into account when counseling elderly patients with 
breast cancer in early stages. 
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Purpose or Objective: Modern day radiation oncologists have 
multiple options of treatment techniques including 3 D 
conformal radiotherapy (3 D CRT), Intensity modulated 
radiotherapy (IMRT) (Step shoot and dynamic) and volumetric 
modulated arc therapy (VMAT). This study assessed the effect 
of incremental treatment complexity on patient treatment 
times and the treatment times for first day and subsequent 
day treatments.  
 
Material and Methods: From Nov 2014 to Feb 2015, data of 
all the patients treated in our department with all techniques 
(3D CRT, IMRT, and VMAT) was analyzed using the Mosaiq 
system. Treatment time as computed by Mosaiq is the 
difference between the time at which the patient record is 
opened in Mosaiq Sequencer for treatment and the time at 
which the activity is captured after all treatment fields are 
completed. Treatment time on the first day and subsequent 
days for each technique was separately analyzed. Data was 
analyzed using SPSS software. 
 
Results: All timings were recorded in minutes. First day 
treatment sessions: For 18 first day sessions of 3 D CRT, the 
average treatment time was 30.37 (SD ±11.57). For 81 first 
day VMAT treatments the average time was 29.49 (SD ± 
35.27) while the corresponding time for 5 dynamic and 
step/shoot IMRT sessions was 13.81 (SD ±7.72). Subsequent 
daily treatments: For 240 sessions of daily treatments of 3D 
CRT, the average treatment time was 15.53(SD ±12.31). For 
2412 daily treatment VMAT sessions, the average treatment 
time was 15.82 (SD ±15.37). For combined dynamic (117 
sessions) and step/shoot IMRT (33 sessions), the average 
treatment time was 19.62 (SD ± 5.77). Overall daily 
treatment times were similar for VMAT as compared to 3 
DCRT (p> 0.05). The difference in treatment times for first 
day treatment versus subsequent first day treatment were 
statistically significant for 3D CRT as well as VMAT.(p<0.05) 
 
Conclusion: More complex radiotherapy techniques like VMAT 
require nearly same treatment times compared to 3 D 
conformal techniques on a daily basis. However, first day 
treatment times for all treatment techniques are significantly 
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more than their corresponding subsequent daily treatment 
times. Radiation oncologists need to be cognizant of these 
issues in everyday management of their patients. 
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Purpose or Objective: Integration of multiple technical 
aspects like treatment prescription, planning, delivery and 
quality assurance is paramount for smooth and efficient 
functioning of any radiotherapy department. In the 
developing world, bearing 60% of global cancer burden, 
efficient management of available resources assumes even 
greater importance. Workflow management software is a tool 
available for effective resource management in radiotherapy. 
The purpose of this audit is to evaluate the impact of 
implementation of workflow management on the 
organisational ergonomics of our department.  
 
Material and Methods: Workflow management software (Aria 
v 11.0™) has been in use in our department since October 
2014. Prior to that, on-paper documentation was the 
predominant mode of communication between physicians and 
physicists for all forms of conformal treatment planning. Case 
records of patients who were treated with conformal 
radiation in the two month period prior to and after the 
implementation of workflow management were 
retrospectively evaluated. Proportion of cases for which 
treatment was started on the day of appointment was taken 
as a surrogate for work efficiency, which was the primary end 
point in this study. Other variables, like time available for 
target delineation (Td), treatment planning (Tp) and plan 
evaluation (Te) were analysed for different conformal 
techniques as secondary end points. 
 
Results: Of the 343 cases analysed, 190 were treated before 
implementation of workflow management (group 1), while 
153 were treated after that (group 2). The mean gap 
between planning CT scans and date of treatment (overall 
planning time, To = Td + Tp + Te) was 5.25 days for group 1 
and 6.53 days for group 2 (p=0.104).  
Among 3D-CRT plans, 29% were not started on the day of 
appointment in group 1, while 20% were not started on time 
in group 2 (p= 0.13). However, mean time available for 
planning and evaluation (Tp + Te) increased from 1.3 days in 
group 1 to 2.8 days in group 2 (p<0.01), without significant 
increase in overall planning time (To). 
In group 1, 71% of IMRT plans were not started on time, while 
only 27.2% were not started on time in group 2 (p<0.0001). 
Overall planning time (To) for IMRT decreased from a mean 
of 9.4 days to 5.9 days, after workflow management 
(p=0.013), without significant compromise in the time 
available for planning and evaluation (Tp + Te). 
On multivariate analysis, workflow management was an 
independent factor determining work efficiency (p=0.04) 
irrespective of the diagnosis, physician or physicist. 
 
Conclusion: Implementation of workflow management 
resulted in significant improvement in work efficiency, as 
evidenced by an increase in proportion of cases started on 
time; this improvement was more substantial for IMRT 
planning. Time available for planning and evaluation also 
significantly increased with workflow management. Such 
improvements in work efficiency are essential for resource 
management in developing countries. 
 
EP-1452  
The impact of individual surgeons on the likelihood of 
mastectomy in breast cancer 
I. Boero1, A. Paravati
1University of California San Diego, Radiation Medicine and 
Applied Sciences, San Diego, USA 
1, R. Matsuno1, E. Gillespie1, J. Einck1, L. 
Mell1, J. Murphy1 
Purpose or Objective: Substantial variations exist in the use 
of mastectomy and breast-conserving surgery (BCS or 
lumpectomy) to treat invasive cancer. No recent analysis has 
queried the broader role of individual surgeons play in the 
decision making process for BCS or mastectomy. The goal of 
this study was to evaluate the impact of individual surgeons 
on surgical procedures for definitive treatment of breast 
cancer in a large cohort of Medicare beneficiaries. 
 
Material and Methods: 36,068 women with non-metastatic 
breast cancer undergoing primary surgery (either BCS or 
mastectomy) were identified from Surveillance, 
Epidemiology, and End Results-Medicare linked database from 
2000 to 2009. Medicare claims were used to determine 
surgery type and provider. Health service area stratified, 
multi-level, multivariable logistic models clustered by 
surgeon were used to determine the impact of surgeons on 
the likelihood of mastectomy while controlling for a patient’s 
clinical and demographic covariates.  
 
Results: 8,327 women were treated with mastectomy. 20.9% 
of the variation in the likelihood of mastectomy was due to 
the individual surgeon; 18.8% of this variation in surgery was 
due to a patient’s clinical and demographic status. The 
median odds ratio, which allows for a direct comparison 
between the effect of the cluster variable (surgeon) and the 
odds ratio (OR) of fixed covariates, was 2.43. The only 
variables with a greater impact than surgeon were regional 
lymph node surgery (OR 3.0, 95% confidence interval [CI]: 
2.79, 3.23) and primary tumor size 2-5 centimeters (OR 2.79, 
95% CI: 2.62, 2.97).  
 
Conclusion: Surgeons have a substantial impact on a 
woman’s likelihood of mastectomy for the treatment of 
invasive breast cancer. Further research should clarify the 
role of the patient in the decision making process. 
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Purpose or Objective: To analyze the status of research on 
heavy ion using the social network analysis methods and 
analytical methods bibliometric methods. 
 
Material and Methods: We searched PubMed database by 
(“heavy ion radiotherapies”[Title/Abstract] OR “heavy ion 
radiotherapy”[Title/Abstract] OR “heavy ion 
therapy”[Title/Abstract] OR “heavy ion 
therapies”[Title/Abstract] OR “heavy ion radiation 
therapies”[Title/Abstract] OR “heavy ion radiation 
therapy”[Title/Abstract] OR “carbon ion 
radiotherapies”[Title/Abstract] OR “carbon ion 
radiotherapy”[Title/Abstract] OR “carbon ion 
therapy”[Title/Abstract] OR “carbon ion 
therapies”[Title/Abstract] OR “carbon ion radiation 
therapies”[Title/Abstract] OR “carbon ion radiation 
therapy”[Title/Abstract] OR "Heavy Ion Radiotherapy"[Mesh]) 
OR ((“hellion ion”[Title/Abstract] OR “hellium 
ion”[Title/Abstract] OR neno[Title/Abstract] OR “carbon 
ion”[Title/Abstract] OR “carbon ions”[Title/Abstract]) AND 
(Radiotherapy[Title/Abstract] OR 
radiotherapies[Title/Abstract] OR “radiation therapy” 
[Title/Abstract] OR “radiation therapies” [Title/Abstract] OR 
("radiotherapy" [Subheading] OR "Radiotherapy"[Mesh])),to 
collect all relevant research on heavy ion. The related 
software was used to extract the information of author, 
country, year of publication, publication year,MeSH terms 
and journal name. SPSS17.0 was used to analyze the 
frequency and percentage. NetDraw software was used to 
draw the social network plot. 
 
Results: 907 studies were retrieved, The number of studies 
on heavy ion were increased from 1975 to 2014, the author 
